PRM-151 therapy well tolerated in patients with advanced myelofibrosis

(University of Texas M. D. Anderson Cancer Center) A study that investigated the potential of the compound PRM-151 for reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.